For the treatment and control of susceptible roundworms (including benzimidazole-resistant small strongyles, ivermectin-resistant Parascaris equorum and the arterial larval stages of strongylus vulgaris), lungworms, tapeworm, bots and skin lesions (Summer sores) caused by cutaneous larvae of Habronema spp.
Product Specifications
Active Constituents
200mg/mL OXIBENDAZOLE
50mg/mL PRAZIQUANTEL
4mg/mL IVERMECTIN